Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study

BACKGROUND: Strong opioids, including oxycodone, are the most effective analgesics used to combat moderate to severe cancer pain, but opioid-induced bowel dysfunction is a relevant problem associated with the therapy. Clinical studies have demonstrated equivalent analgesic efficacy and improved bowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolte, Thomas, Schutter, Ulf, Loewenstein, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045016/
https://www.ncbi.nlm.nih.gov/pubmed/27774024
http://dx.doi.org/10.2147/POR.S49793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045016/
https://www.ncbi.nlm.nih.gov/pubmed/27774024
http://dx.doi.org/10.2147/POR.S49793

Ejemplares similares